Samsung Biologics

207940.KO

733.24 USD

-3.15

-0.43%

Overview

Last close

733.24 usd

Market cap

52.19B usd

52 week high

761.21 usd

52 week low

522.84 usd

Target price

736.19 usd

Valuation

P/E

N/A

Forward P/E

48.7805

Price/Sales

14.4711

Price/Book Value

6.3034

Enterprise Value

52.44B usd

EV/Revenue

14.5421

EV/EBITDA

31.0762

Key financials

Revenue TTM

3.61B usd

Gross Profit TTM

1.90B usd

EBITDA TTM

1.62B usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

11.83B usd

Net debt

N/A usd

About

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates through Contract Development and Manufacturing Organization (CDMO), and Biopharmaceutical Development and Commercialization segments. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and regulatory support services; and quality, biosafety and analytical testing services, as well as manufactures drug substance. In addition, it engages in the development and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.